ROBERTSON MICHELLE 4
4 · Editas Medicine, Inc. · Filed May 15, 2023
Insider Transaction Report
Form 4
ROBERTSON MICHELLE
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-05-11$9.87/sh−949$9,369→ 106,610 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 10, 2023. The sale does not represent a discretionary trade by the Reporting Person.